Philip Morris stock gains analyst support as Argus lifts target to USD 220
Published on 10/31/2026 at 10:49 | Editorial responsibility: Rafael Müller, Editor-in-Chief AD HOC NEWSAnalysts raise smoke-free expectations
- Argus lifted its Philip Morris price target after the company beat third-quarter expectations.
- Goldman Sachs maintained a Buy rating as smoke-free products continued to support the investment case.
- VEEV shipment growth added momentum to Philip Morris' smoke-free portfolio during the third quarter.
Analyst sentiment toward Philip Morris strengthened during the week after Argus raised its price target and Goldman Sachs reaffirmed its Buy rating. The moves followed the tobacco group's third-quarter performance and its continued expansion in smoke-free products.
Argus raises target after quarterly beat
Argus lifted its target to USD 220 from USD 210 on October 26 and kept a Buy rating, according to Markets Insider. The analyst cited progress in smoke-free products, particularly IQOS, and said Philip Morris held three quarters of volume share in the category.
Goldman Sachs maintained its Buy stance on October 28 with a USD 222 target. Together, the analyst actions point to continued confidence in Philip Morris' ability to expand its reduced-risk portfolio, although target prices remain analyst estimates rather than operating results.
Smoke-free products remain central
Philip Morris reported third-quarter net revenue of USD 11.4 billion, up 5.5 percent from a year earlier. Smoke-free shipments increased 2.7 percent, while VEEV shipments rose 61.6 percent, adding product-level momentum beyond the group's established IQOS and ZYN businesses.
At Lang & Schwarz, Philip Morris stock's real-time quote was EUR 187.15 at 10:45 CET on Saturday, October 31, 2026.
Philip Morris International at a glance
- Company: Philip Morris International Inc.
- ISIN: US7181721090
- NYSE ticker: PM
- Lang & Schwarz quote: EUR 187.15 at 10:45 CET on October 31, 2026
The broader U.S. equity market remains the relevant backdrop for the company, with investors weighing defensive consumer exposure against valuation and growth expectations in the S&P 500.
